Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Breakthrough T1D, Lupus Research Alliance, and National Multiple Sclerosis Society Award Nearly $1M to Fuel Autoimmune Disease Discovery

      Lupus Research Alliance

      News provided by

      Lupus Research Alliance

      Nov 18, 2026, 10:00 ET

      Share this article

      Share this article


      Research funding will aim to decode understanding across autoimmune diseases

      NEW YORK, Nov. 18, 2026 /PRNewswire/ -- Today, leading autoimmune disease nonprofits – Breakthrough T1D (formerly JDRF), the Lupus Research Alliance, and the National Multiple Sclerosis Society – announced the latest recipients of the Common Mechanisms in Autoimmunity Insight Award, which supports projects investigating commonalities across autoimmune diseases to further our understanding of how they develop to accelerate potential treatments for multiple diseases.

      Continue Reading
      Breakthrough T1D (formerly JDRF), the Lupus Research Alliance, and the National Multiple Sclerosis Society announce the recipients of the Common Mechanisms of Autoimmunity Insight Award.
      Breakthrough T1D (formerly JDRF), the Lupus Research Alliance, and the National Multiple Sclerosis Society announce the recipients of the Common Mechanisms of Autoimmunity Insight Award.

      Autoimmune diseases cause the body to attack its own cells, tissues, and organs, causing inflammation, damage, and loss of function. Roughly 10% of the population will be diagnosed with an autoimmune disease, with an increased likelihood of developing a second. By looking at shared mechanisms across type 1 diabetes (T1D), systemic lupus erythematosus (SLE), and multiple sclerosis (MS), the Common Mechanisms in Autoimmunity program aims to close gaps in understanding across research areas more efficiently and effectively than working independently.

      "For people living with autoimmune diseases, time matters," Maya Bader, PhD, Director of Research at the Lupus Research Alliance, said. "By combining resources and fostering cross-disciplinary collaboration, we are accelerating the path toward overcoming the challenges of developing cures and therapies for several diseases."

      This year, six recipients were selected after a highly rigorous review process and will each receive up to $150,000 to fund a 1-year pilot investigation. Representing leading academic institutions in the U.S. and Europe, the recipients are:

      • Maya Arce, PhD, Arc Institute
        • Many autoimmune diseases arise from the combined effects of numerous genetic variants, yet most research has examined these variants one at a time, limiting a full understanding of disease risk. Dr. Arce will study how combinations of risk variants interact to disrupt key immune signaling pathways, particularly those controlling CD4+ T cells (a type of immune cell that helps coordinate immune responses and is often improperly activated in autoimmune disease). These findings could help identify more precise treatment targets and match therapies to an individual's genetic profile.
      • Ka Lung Cheung, PhD, Icahn School of Medicine at Mount Sinai
        • The Th17 immune pathway plays a central role in many autoimmune diseases, but therapies targeting a single inflammatory molecule have often been ineffective. Dr. Cheung will investigate how Th17 plasticity — the ability of these immune cells to shift and produce multiple inflammatory signals — is controlled, focusing on a key regulator called Hdac7 and testing a targeted inhibitor in models of MS, SLE, and T1D. This work aims to establish a new, more effective therapeutic strategy by targeting the underlying mechanisms of harmful immune activity across a range of conditions.
      • Gabriela Fragiadakis, PhD, The Regents of the University of California, San Francisco
        • Autoimmune diseases are typically studied as separate conditions, even though they may share underlying immune system dysfunction. Dr. Fragiadakis will combine large-scale single-cell datasets of over a million individual immune cells to identify shared patterns in immune cell behavior and gene activity across these diseases, creating a new framework based on common biological "archetypes" rather than traditional diagnoses. This approach aims to enable more efficient drug development, opening the door to treatments applicable across multiple autoimmune conditions.
      • Jill Norris, PhD, MPH, Regents of the University of Colorado
        • Autoimmune diseases develop over time through a combination of genetic risk and environmental exposures, often beginning years before symptoms appear. Dr. Norris will explore whether exposure to environmental chemicals such as PFAS, phenols, and phthalates is linked to the onset and progression of SLE, MS, T1D, and rheumatoid arthritis by analyzing samples from individuals at risk before diagnosis. This work aims to uncover preventable environmental drivers of autoimmune disease and enable the development of environmental interventions to reduce the risk of disease development.
      • Thomas Pieber, MD, Medical University of Graz – Austria
        • SLE, MS, and T1D share some mechanisms but differ in how patients respond to treatment, reflecting gaps in understanding the underlying biology of the diseases. Dr. Pieber will study a key immune signaling pathway, JAK/STAT, by testing how already-approved drugs called JAK inhibitors affect immune cells from patients across these diseases, identifying both shared and disease-specific responses. This study builds on extensive findings from earlier research and aims to accelerate the repurposing of existing drugs and identify the most promising JAK inhibitors for future development.
      • Ingrid Kockum, PhD, Karolinska Institutet – Sweden
        • While several autoimmune diseases share genetic and biological risk factors, they also differ in how the immune system drives disease. Dr. Kockum will use large-scale genetic, health registry, and lifestyle data, along with advanced analytical and artificial intelligence tools, to identify shared and disease-specific mechanisms, improve early prediction models, and uncover opportunities to repurpose existing drugs. This work aims to enable earlier diagnosis, more targeted prevention strategies, and the development of tailored autoimmune treatments.

      "The selected projects represent some of the most promising and rigorous research in the field today, with implications that reach across many autoimmune diseases," James Quinn, PhD, Director of Biomedical Research at the National MS Society, said. "We're excited to support work that could redefine therapeutic pathways on a broader scale."

      Since its inception in 2021, the program has awarded 19 pilot investigations in this cross-collaborative effort – reflecting a more unified approach across autoimmune research. As a result of this funding, Aly Khan, PhD, University of Chicago, published a high-profile paper in Nature Biotechnology featuring his project identifying tiny protein fragments – called peptides – that may trigger autoimmune diseases, ultimately working to chart a path toward more personalized and effective treatments.

      "This program reflects a forward-looking approach to research – one that prioritizes collaboration, speed, and research excellence," Joshua Vieth, PhD, Senior Director of Research at Breakthrough T1D, said. "This is how we will drive the next generation of autoimmune disease breakthroughs."

      The Request for Applications (RFA) for the 2027 Common Mechanisms in Autoimmunity Insight Award is now open. Applications are due January 7, 2027. To learn more about the program and selected projects, visit DecodingAutoimmunity.org.

      About Breakthrough T1D, Formerly JDRF
      As the leading global type 1 diabetes (T1D) research and advocacy organization, Breakthrough T1D (formerly JDRF) helps make everyday life with type 1 diabetes better while driving toward cures. We do this by investing in the most promising research, advocating for progress by working with government to address issues that impact the T1D community, and helping educate and empower individuals facing this condition. Learn more and get involved at X, Facebook, Instagram, and LinkedIn. 

      About the Lupus Research Alliance
      The Lupus Research Alliance is the largest non-governmental, non-profit funder of lupus research worldwide. The organization aims to transform treatment by funding the most innovative lupus research, fostering scientific talent, and driving discovery toward better diagnostics, improved treatments and, ultimately, a cure for lupus. Because the Lupus Research Alliance's Board of Directors funds all administrative and fundraising costs, 100% of all donations go to support lupus research programs. For more information or to donate to lupus research, visit the LRA at LupusResearch.org and on social media at: X, Facebook, LinkedIn, and Instagram.

      About the National Multiple Sclerosis Society
      The National MS Society, founded in 1946, is the global leader of a growing movement dedicated to creating a world free of MS. The Society funds cutting-edge research for a cure, drives change through advocacy and provides programs and services to help people affected by MS live their best lives. Connect to learn more and get involved: nationalmssociety.org, Facebook, X (formerly known as Twitter), Instagram, YouTube or 1-800-344-4867.

      SOURCE Lupus Research Alliance

      Modal title

      Also from this source

      2026 Lupus Research Alliance Gala Raises Millions to Advance Lupus Research Breakthroughs

      2026 Lupus Research Alliance Gala Raises Millions to Advance Lupus Research Breakthroughs

      The Lupus Research Alliance (LRA), the world's largest private funder of lupus research, hosted its annual Breaking Through Gala last night at the...

      Lupus Research Alliance Awards Lupus Insight Prize for Critical Discovery of TLR7 Immune Control Sensor Failure Driving Lupus

      Lupus Research Alliance Awards Lupus Insight Prize for Critical Discovery of TLR7 Immune Control Sensor Failure Driving Lupus

      The Lupus Research Alliance, the world's largest private funder of lupus research, proudly awarded the 2026 Lupus Insight Prize to Gregory Barton,...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Computer & Electronics

      Computer & Electronics

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Clinical Trials & Medical Discoveries

      Clinical Trials & Medical Discoveries

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.